美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Pernix Therapeutics Holdings

0.2070

0.0000

成交量：- -

成交額：- -

市值：300.27萬

市盈率：-0.03

高：0.2070

開：0.2070

低：0.2070

收：0.2070

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Pernix Therapeutics Holdings

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.pernixtx.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Pernix Therapeutics Holdings, Inc.於1996年11月8日在馬里蘭州註冊成立。公司是一家特種藥物生產企業，主要對一系列品牌及基因醫藥產品進行售賣、市場營銷、生產和研發，這些醫藥產品主要應用於失眠、細菌感染以及咳嗽和感冒癥狀。公司希望通過酌情把其產品推銷給內科醫生、衛生保健行業從業者以及顧客，以此來預見公司業績的持續增長。自成立之日起，公司便參与了多項併購重組以及許可證協議，以此希望擴大其產品銷售渠道。作為其部分擴張戰略，公司計劃對其他產品和公司進行戰略收購，同時研發並引進額外產品，其目的是將慢性、非季節性的特種產品引入到其利潤範圍中。其品牌產品包括先力騰（CEDAX），它是治療中耳炎的抗生素類藥物，同時也是治療咳嗽和感冒的處方藥（包括ZUTRIPRO, REZIRA和VITUZ）。公司還對多賽平（SILENOR）進行市場營銷，該物可以治療失眠症（對睡眠維持有困難），同時不受買賣控制。公司通過售賣及市場營銷組織宣傳其品牌藥物。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PTX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTX\",,,,,undefined,":{"symbol":"PTX","market":"US","secType":"STK","nameCN":"Pernix Therapeutics Holdings","latestPrice":0.207,"timestamp":1552680000000,"preClose":0.207,"halted":0,"volume":0,"delay":0,"floatShares":13322183,"shares":14505848,"eps":-6.260195,"marketStatus":"未開盤","change":0,"latestTime":"03-15 16:00:00 EDT","open":0.207,"high":0.207,"low":0.207,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-6.260195,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1753430400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":855291600000,"exchange":"NASDAQ","adjPreClose":0.207,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTX\",,,,,undefined,":{"symbol":"PTX","floatShares":13322183,"roa":"--","roe":"--","lyrEps":-7.205398,"shares":14505848,"dividePrice":0,"high":0.207,"amplitude":0,"preClose":0.207,"low":0.207,"week52Low":0.203,"pbRate":"-0.01","week52High":3.3,"institutionHeld":0.7448,"latestPrice":0.207,"eps":-6.260195,"divideRate":0,"volume":0,"delay":0,"ttmEps":-6.260195,"open":0.207,"prevYearClose":0.207},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.pernixtx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.0456},{"period":"3month","weight":0.1522},{"period":"6month","weight":0.0435},{"period":"1year","weight":0.1722},{"period":"ytd","weight":0.0825}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Pernix Therapeutics Holdings, Inc.於1996年11月8日在馬里蘭州註冊成立。公司是一家特種藥物生產企業，主要對一系列品牌及基因醫藥產品進行售賣、市場營銷、生產和研發，這些醫藥產品主要應用於失眠、細菌感染以及咳嗽和感冒癥狀。公司希望通過酌情把其產品推銷給內科醫生、衛生保健行業從業者以及顧客，以此來預見公司業績的持續增長。自成立之日起，公司便參与了多項併購重組以及許可證協議，以此希望擴大其產品銷售渠道。作為其部分擴張戰略，公司計劃對其他產品和公司進行戰略收購，同時研發並引進額外產品，其目的是將慢性、非季節性的特種產品引入到其利潤範圍中。其品牌產品包括先力騰（CEDAX），它是治療中耳炎的抗生素類藥物，同時也是治療咳嗽和感冒的處方藥（包括ZUTRIPRO, REZIRA和VITUZ）。公司還對多賽平（SILENOR）進行市場營銷，該物可以治療失眠症（對睡眠維持有困難），同時不受買賣控制。公司通過售賣及市場營銷組織宣傳其品牌藥物。","exchange":"NASDAQ","name":"Pernix Therapeutics Holdings","nameEN":"Pernix Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PTX\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-11-08","symbol":"PTX","fiscalQuarterEnding":"2018/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1541653200000,"reportTimeType":"","actualEps":-0.89},{"market":"US","date":"2018-08-09","symbol":"PTX","fiscalQuarterEnding":"2018/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1533787200000,"reportTimeType":"","actualEps":-1.13},{"market":"US","date":"2018-05-10","symbol":"PTX","fiscalQuarterEnding":"2018/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1525924800000,"reportTimeType":"","actualEps":-1.57},{"market":"US","date":"2018-03-08","symbol":"PTX","fiscalQuarterEnding":"2017/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1520485200000,"reportTimeType":"","actualEps":-2.78},{"market":"US","date":"2017-11-07","symbol":"PTX","fiscalQuarterEnding":"2017/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1510030800000,"reportTimeType":"","actualEps":-0.57}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTX\",market:\"US\",delay:false,,,undefined,":{}}}